FBT
TEVA icon

First Bank & Trust’s Teva Pharmaceuticals TEVA Stock Holding History

First Bank & Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-179
Closed -$3K – 290
2018
Q4 		$3K Sell
179
-179
-50% -$3.67K ﹤0.01% 253
2018
Q3 		$8K Hold
358
– – 0.01% 234
2018
Q2 		$9K Hold
358
– – 0.01% 231
2018
Q1 		$6K Hold
358
– – ﹤0.01% 232
2017
Q4 		$7K Sell
358
-491
-58% -$7.39K 0.01% 233
2017
Q3 		$15K Sell
849
-737
-46% -$16.6K 0.01% 217
2017
Q2 		$53K Sell
1,586
-103
-6% -$3.19K 0.04% 190
2017
Q1 		$54K Sell
1,689
-254
-13% -$8.67K 0.05% 194
2016
Q4 		$70K Buy
+1,943
New +$77.6K 0.06% 184

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Bank & Trust's TEVA Position: Q1 2019 in Review

First Bank & Trust sold out of Teva Pharmaceuticals (TEVA) in Q1 2019, closing a stake of 179 shares — an estimated $3K sold.

First Bank & Trust first reported a position in TEVA in Q4 2016 and held it in 9 quarters. The position peaked at $70K in Q4 2016. 521 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

  • First Bank & Trust reported no remaining Teva Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • First Bank & Trust sold 179 Teva Pharmaceuticals shares in Q1 2019, an estimated $3K.
  • First Bank & Trust first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 9 quarters.
  • First Bank & Trust's Teva Pharmaceuticals position peaked at $70K in Q4 2016.
  • 521 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2019.

Based on First Bank & Trust's 13F filing for Q1 2019, filed 15 Apr 2019.